Search results

...rapies]], [[tissue (biology)|tissues]], [[recombinant proteins|recombinant therapeutic protein]], and [[living medicine]]s used in [[cell therapy]]. Biologics can ...egulatory agencies]] use the terms ''biological medicinal products'' or '''therapeutic biological product''' to refer specifically to engineered [[macromolecule|m ...

...ood of the patient developing their own antibodies against the therapeutic antibody) <ref name = AMA/> || [[infliximab]] | -zumab || [[humanized antibody]]<ref name=EBSCO>{{cite book | chapter-url = http://connection.ebscohost.co ...

...'monoclonal antibody''' ('''mAb''', more rarely called '''moAb''') is an [[antibody]] produced from a [[Lineage (evolution)|cell lineage]] made by [[cloning]] ...lso be engineered, by increasing the therapeutic targets of one monoclonal antibody to two epitopes. ...

...as [[lead compound|leads]] in the development of new [[pharmaceutical drug|therapeutic agents]]. Some can inhibit a specific function of a protein or disrupt [[pr ...c medical product]]s). With the exception of [[Monoclonal antibody therapy|therapeutic antibodies]], many proteins are degraded if administered orally and most of ...

...ore than 50 biosimilars since 2006. The first biosimilar of a [[monoclonal antibody]] to be approved worldwide was a biosimilar of [[infliximab]] in the EU in ...ased biological substance for eventual development of a drug. [[Monoclonal antibody]] technology combined with recombinant DNA technology has paved the way for ...

...rapeutic effect/ja|治療効果]]によって医薬品を分類する方法がある。精巧で広く使われている分類システムに、[[Anatomical Therapeutic Chemical Classification System/ja|解剖学的治療化学分類システム]]がある。[[:en:World Health Or ...用または活性などの薬理学的特性に基づいて、その起源以外にも様々なグループに分類される。精巧で広く使われている分類システムに、[[Anatomical Therapeutic Chemical Classification System/ja|解剖学的治療化学分類システム]]（ATCシステム）がある。[[World Heal ...

...ore than 50 biosimilars since 2006. The first biosimilar of a [[monoclonal antibody]] to be approved worldwide was a biosimilar of [[infliximab]] in the EU in ...ased biological substance for eventual development of a drug. [[Monoclonal antibody]] technology combined with recombinant DNA technology has paved the way for ...

...houghts and feelings go a long way in therapy recovery, this is called the therapeutic process.<ref>{{Cite web |date=2020-07-20 |title=Psychotherapy: What to expe **** by [[humoral immunity|humoral immune factors]]: antibody therapy ...

...d in a variety of conditions, many of which involve decreased or abolished antibody production capabilities, which range from a complete absence of multiple ty ...Supply and indications are classified as either an established or emerging therapeutic role or conditions for which immunoglobulin use is in exceptional circumsta ...

...is the [[Anatomical Therapeutic Chemical Classification System|Anatomical Therapeutic Chemical Classification System]]. The [[:en:World Health Organization|World ...is the [[Anatomical Therapeutic Chemical Classification System|Anatomical Therapeutic Chemical Classification System]] (ATC system). The [[World Health Organizat ...

...is the [[Anatomical Therapeutic Chemical Classification System|Anatomical Therapeutic Chemical Classification System]]. The [[:en:World Health Organization|World ...is the [[Anatomical Therapeutic Chemical Classification System|Anatomical Therapeutic Chemical Classification System]] (ATC system). The [[World Health Organizat ...

* [[immune/ja|免疫]]保護に重要な役割を果たす[[T helper cell/ja|Tヘルパー細胞]]、[[Antibody/ja|抗体]]、[[leukocyte/ja|白血球]]、[[cytokine/ja|サイトカイン]]、[[lymph/ja|リンパ]]機構の産生を刺 ...gement of Inflammatory Bowel Disease". ''Biomedicines'', '''10'''(6: Novel Therapeutic Approaches in Inflammatory Bowel Diseases 2.0 (special issue)), 1242. {{Doi ...

...eins are widely used as reagents in laboratory experiments and to generate antibody probes for examining protein synthesis within cells and organisms.<ref name ...l growth and development. Before recombinant HGH became available, HGH for therapeutic use was obtained from pituitary glands of cadavers. This unsafe practice le ...

**Admune Therapeutic <small>(Acq 2015)</small> ...を販売しており、これは[[:en:bevacizumab|ベバシズマブ]]（アバスチン）と同じ親マウス抗体に由来する[[:en:monoclonal antibody|モノクローナル抗体断]]片である。 ...

...s = Melief CJ, van Hall T, Arens R, Ossendorp F, van der Burg SH | title = Therapeutic cancer vaccines | journal = The Journal of Clinical Investigation | volume ...ite book |last1=Justiz Vaillant |first1=AA |last2=Ramphul |first2=K |title=Antibody Deficiency Disorder |location=Treasure Island, FL |publisher=StatPearls Pub ...

...|title=The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. |journal=Translational Psychiatry |date=11 November 2019 |volum ...vanc |title=The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorect ...

...90 | pmid = 2381442 | doi = 10.1056/NEJM199008303230904 }}</ref> The first therapeutic use of gene transfer as well as the first direct insertion of human DNA int ...ion of the mutation that causes sickle cell disease, may be available as a therapeutic option in the future.<ref>{{cite journal | vauthors = Dever DP, Bak RO, Rei ...

...arly routine use of insulin for type 2 diabetes mellitus can prove to be a therapeutic and behavioral challenge. ...insulin cases reported to poison centers are unintentional, as a result of therapeutic error. Another 10% of cases are intentional, and may reflect attempted suic ...

* stimulate production of [[T helper cell]]s, [[Antibody|antibodies]], [[leukocyte]]s, [[cytokine]]s, and [[lymph]] mechanisms havin ...gement of Inflammatory Bowel Disease". ''Biomedicines'', '''10'''(6: Novel Therapeutic Approaches in Inflammatory Bowel Diseases 2.0 (special issue)), 1242. {{Doi ...

...arly routine use of insulin for type 2 diabetes mellitus can prove to be a therapeutic and behavioral challenge. ...insulin cases reported to poison centers are unintentional, as a result of therapeutic error. Another 10% of cases are intentional, and may reflect attempted suic ...